0001891669-21-000001.txt : 20211102 0001891669-21-000001.hdr.sgml : 20211102 20211102130429 ACCESSION NUMBER: 0001891669-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 EFFECTIVENESS DATE: 20211102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Red Queen Therapeutics, Inc. CENTRAL INDEX KEY: 0001891669 IRS NUMBER: 872028563 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-419494 FILM NUMBER: 211370109 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 203-232-7865 MAIL ADDRESS: STREET 1: 245 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001891669 Red Queen Therapeutics, Inc. 245 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02142 203-232-7865 DELAWARE None None Corporation true 2021 Paul Da Silva Jardine c/o Red Queen Therapeutics, Inc. 245 Main Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Seth Harrison c/o Red Queen Therapeutics, Inc. 245 Main Street Cambridge MA MASSACHUSETTS 02142 Director Spiros Liras c/o Red Queen Therapeutics, Inc. 245 Main Street Cambridge MA MASSACHUSETTS 02142 Director Loren Walensky c/o Red Queen Therapeutics, Inc. 245 Main Street Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2021-10-13 false true false 0 55000000 5000000 50000000 false 1 0 0 0 false Red Queen Therapeutics, Inc. /s/ Paul Da Silva Jardine Paul Da Silva Jardine President 2021-11-02